ArticleScientific reports2025
Tracking temporal progression of benign bone tumors through X-ray based detection and segmentation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
X-ray is the most widely used imaging modality for the initial diagnosis of bone tumors due to its accessibility and cost-effectiveness. However, the longitudinal comparison of benign bone tumors, particularly for assessing size and shape progression over time, remains largely manual and subjective. In this study, we propose FusionX-BBTNet, a deep learning-based framework that enables automated detection, segmentation, and time-sequential analysis of BBTs from X-ray images. The framework combines YOLO-based object detection with U-Net segmentation, and utilizes a novel wavelet-enhanced dataset to improve contour accuracy. To enable real-world quantification, an OCR-based module is used to extract the X-ray scale bar and compute the pixel-to-length conversion ratio. With this, tumor size and area are calculated in millimeters, and their changes over time are visualized through centroid-based alignment. The proposed method was validated on a dataset of 466 expert-annotated X-ray images, achieving a mean IoU of 0.9376 and a boundary F1 score of 0.9827. In addition to providing reliable tumor localization and measurement, the system supports clinical decision-making by offering intuitive shape and area comparisons. This approach has the potential to complement expert interpretation and improve diagnostic efficiency, especially in environments with limited radiological expertise.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.